Skip to main content
. 2023 Mar 5;19(5):1645–1663. doi: 10.7150/ijbs.81939

Figure 5.

Figure 5

The implication of the BMscore on breast cancer treatment resistance. (A, B and C) The relationship between the BMscore and treatment sensitivity in TCGA-BRCA, including chemotherapy (A), endocrine therapy (B) and radiotherapy (C). (D, E and F) The relationship between the BMscore and treatment sensitivity in METABRIC, including chemotherapy (D), endocrine therapy (E) and radiotherapy (F).